Bard Financial Services, Inc. - Medexus Pharmaceutical ownership

Quarter-by-quarter ownership
Bard Financial Services, Inc. ownership history of Medexus Pharmaceutical
ValueSharesWeighting
Q2 2023$14,058
+18.9%
10,0000.0%0.00%0.0%
Q1 2023$11,824
+78726.7%
10,0000.0%0.00%0.0%
Q4 2022$1510,0000.00%
Other shareholders

There were no reported owners of Medexus Pharmaceutical in Q3 2023.

NameSharesValueWeighting ↓
View complete list of Medexus Pharmaceutical shareholders